Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis
2015 · Scientific Reports · 73 citations
https://doi.org/10.1038/srep16599
W
Wenzhi Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
1.9K
Citations
25
h-index
45
i10-index
Wenzhi Shen is an academic researcher from Shandong University. The author has contributed to research in topics: Phosphodiesterase function and regulation & RNA modifications and cancer & Atrial Fibrillation Management and Outcomes. The author has an h-index of 25, co-authored 82 publications.
ORCID: 0000-0002-4251-6035Papers by this author
worksIbuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner
2020 · British Journal of Cancer · 38 citations
https://doi.org/10.1038/s41416-020-0906-7
Function and regulation of RGS family members in solid tumours: a comprehensive review
2023 · Cell Communication and Signaling · 26 citations
https://doi.org/10.1186/s12964-023-01334-7
PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner
2019 · Oncogenesis · 25 citations
https://doi.org/10.1038/s41389-019-0162-y
Additional Lesion Sets in Ablation of Outflow Tract Premature Ventricular Contractions
2024 · JAMA Cardiology · 5 citations
https://doi.org/10.1001/jamacardio.2024.2975
Rationale and study design for empirical additional lesions for premature ventricular complex from the outflow tract: a multi-center, prospective randomized trial (EASE-PVC study)
2022 · Journal of Interventional Cardiac Electrophysiology · 2 citations
https://doi.org/10.1007/s10840-022-01322-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat